<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35816681</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1929-0748</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>10</Day></PubDate></JournalIssue><Title>JMIR research protocols</Title><ISOAbbreviation>JMIR Res Protoc</ISOAbbreviation></Journal><ArticleTitle>The Facilitation of Clinical and Therapeutic Discoveries in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Related Diseases: Protocol for the You + ME Registry Research Platform.</ArticleTitle><Pagination><StartPage>e36798</StartPage><MedlinePgn>e36798</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e36798</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/36798</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic, complex, heterogeneous disease that affects millions and lacks both diagnostics and treatments. Big data, or the collection of vast quantities of data that can be mined for information, have transformed the understanding of many complex illnesses, such as cancer and multiple sclerosis, by dissecting heterogeneity, identifying subtypes, and enabling the development of personalized treatments. It is possible that big data can reveal the same for ME/CFS.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aims to describe the protocol for the You + ME Registry, present preliminary results related to participant enrollment and satisfaction, and discuss the limitations of the registry as well as next steps.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We developed and launched the You + ME Registry to collect longitudinal health data from people with ME/CFS, people with long COVID (LC), and control volunteers using rigorous protocols designed to harmonize with other groups collecting data from similar groups of people.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">As of September 30, 2021, the You + ME Registry had over 4200 geographically diverse participants (3033/4339, 69.9%, people with ME/CFS; 833/4339, 19.2%, post-COVID-19 people; and 473/4339, 10.9%, control volunteers), with an average of 72 new people registered every week. It has qualified as "great" using a net promotor score, indicating registrants are likely to recommend the registry to a friend. Analyses of collected data are currently underway, and preliminary findings are expected in the near future.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The You + ME Registry is an invaluable resource because it integrates with a symptom-tracking app, as well as a biorepository, to provide a robust and rich data set that is available to qualified researchers. Accordingly, it facilitates collaboration that may ultimately uncover causes and help accelerate the development of therapies.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov NCT04806620; https://clinicaltrials.gov/ct2/show/NCT04806620.</AbstractText><AbstractText Label="INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)" NlmCategory="UNASSIGNED">DERR1-10.2196/36798.</AbstractText><CopyrightInformation>&#xa9;Allison Ramiller, Kathleen Mudie, Elle Seibert, Sadie Whittaker. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 10.08.2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ramiller</LastName><ForeName>Allison</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3928-6494</Identifier><AffiliationInfo><Affiliation>Solve ME/CFS Initiative, Glendale, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mudie</LastName><ForeName>Kathleen</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-7950-8680</Identifier><AffiliationInfo><Affiliation>Solve ME/CFS Initiative, Glendale, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seibert</LastName><ForeName>Elle</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-6262-3965</Identifier><AffiliationInfo><Affiliation>Solve ME/CFS Initiative, Glendale, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whittaker</LastName><ForeName>Sadie</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5686-2959</Identifier><AffiliationInfo><Affiliation>Solve ME/CFS Initiative, Glendale, CA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04806620</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>U24 NS105535</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Res Protoc</MedlineTA><NlmUniqueID>101599504</NlmUniqueID><ISSNLinking>1929-0748</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>JMIR Res Protoc. 11:e42030.</RefSource><PMID Version="1">36229036</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">data acquisition source</Keyword><Keyword MajorTopicYN="N">digital health</Keyword><Keyword MajorTopicYN="N">health application</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">longitudinal cohort study</Keyword><Keyword MajorTopicYN="N">longitudinal health data</Keyword><Keyword MajorTopicYN="N">mobile health</Keyword><Keyword MajorTopicYN="N">myalgic encephalomyelitis/chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">patient powered</Keyword><Keyword MajorTopicYN="N">postinfectious</Keyword><Keyword MajorTopicYN="N">symptom-tracking app</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>11</Day><Hour>16</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35816681</ArticleId><ArticleId IdType="pmc">PMC9369615</ArticleId><ArticleId IdType="doi">10.2196/36798</ArticleId><ArticleId IdType="pii">v11i8e36798</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Valdez AR, Hancock EE, Adebayo S, Kiernicki DJ, Proskauer D, Attewell JR, Bateman L, DeMaria A, Lapp CW, Rowe PC, Proskauer C. Estimating prevalence, demographics, and costs of ME/CFS using large scale medical claims data and machine learning. Front Pediatr. 2018 Jan 8;6:412. doi: 10.3389/fped.2018.00412. doi: 10.3389/fped.2018.00412.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2018.00412</ArticleId><ArticleId IdType="doi">10.3389/fped.2018.00412</ArticleId><ArticleId IdType="pmc">PMC6331450</ArticleId><ArticleId IdType="pubmed">30671425</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L, Mirin A. Updating the National Academy of Medicine ME/CFS prevalence and economic impact figures to account for population growth and inflation. Fatigue: Biomed Health Behav. 2021 Jan 28;9(1):9&#x2013;13. doi: 10.1080/21641846.2021.1878716. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2021.1878716</ArticleId><ArticleId IdType="doi">10.1080/21641846.2021.1878716</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes Rivera M, Mastronardi C, Silva-Aldana C, Arcos-Burgos M, Lidbury B. Myalgic encephalomyelitis/chronic fatigue syndrome: a comprehensive review. Diagnostics (Basel) 2019 Aug 07;9(3):91. doi: 10.3390/diagnostics9030091. 
 
diagnostics9030091</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics9030091</ArticleId><ArticleId IdType="pmc">PMC6787585</ArticleId><ArticleId IdType="pubmed">31394725</ArticleId></ArticleIdList></Reference><Reference><Citation>Collin SM, Bakken IJ, Nazareth I, Crawley E, White PD. Trends in the incidence of chronic fatigue syndrome and fibromyalgia in the UK, 2001-2013: a Clinical Practice Research Datalink study. J R Soc Med. 2017 Jun;110(6):231&#x2013;244. doi: 10.1177/0141076817702530. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0141076817702530?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</ArticleId><ArticleId IdType="doi">10.1177/0141076817702530</ArticleId><ArticleId IdType="pmc">PMC5499564</ArticleId><ArticleId IdType="pubmed">28358988</ArticleId></ArticleIdList></Reference><Reference><Citation>Solve ME/CFS Initiative  About the Ramsay Grant Program.  [2022-07-14].  
 https://solvecfs.org/research-and-registry/ramsay-research-grants/
</Citation></Reference><Reference><Citation>Siegel SD, Antoni MH, Fletcher MA, Maher K, Segota MC, Klimas N. Impaired natural immunity, cognitive dysfunction, and physical symptoms in patients with chronic fatigue syndrome: preliminary evidence for a subgroup? J Psychosom Res. 2006 Jun;60(6):559&#x2013;566. doi: 10.1016/j.jpsychores.2006.03.001. 
 
S0022-3999(06)00097-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2006.03.001</ArticleId><ArticleId IdType="pubmed">16731230</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal A, Bradley A, Bishop K, Kiani-Alikhan S, Ford B. Chronic fatigue syndrome, the immune system and viral infection. Brain Behav Immun. 2012 Jan;26(1):24&#x2013;31. doi: 10.1016/j.bbi.2011.06.016. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2011.06.016</ArticleId><ArticleId IdType="pubmed">21756995</ArticleId></ArticleIdList></Reference><Reference><Citation>Cliff JM, King EC, Lee J, Sep&#xfa;lveda N, Wolf A, Kingdon C, Bowman E, Dockrell HM, Nacul L, Lacerda E, Riley EM. Cellular immune function in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Front Immunol. 2019 Apr 16;10:796. doi: 10.3389/fimmu.2019.00796. doi: 10.3389/fimmu.2019.00796.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00796</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2019.00796</ArticleId><ArticleId IdType="pmc">PMC6477089</ArticleId><ArticleId IdType="pubmed">31057538</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweetman E, Noble A, Edgar C, Mackay A, Helliwell A, Vallings R, Ryan M, Tate W. Current research provides insight into the biological basis and diagnostic potential for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Diagnostics (Basel) 2019 Jul 10;9(3):73. doi: 10.3390/diagnostics9030073. 
 
diagnostics9030073</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics9030073</ArticleId><ArticleId IdType="pmc">PMC6787691</ArticleId><ArticleId IdType="pubmed">31295930</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang S, Liew P, Ansar M, Lin S, Wang S, Hung C, Chen J, Jain S, Lin R. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction. Clin Epigenet. 2020 May 12;12(1):67. doi: 10.1186/s13148-020-00855-z. 
 
10.1186/s13148-020-00855-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-020-00855-z</ArticleId><ArticleId IdType="doi">10.1186/s13148-020-00855-z</ArticleId><ArticleId IdType="pmc">PMC7218647</ArticleId><ArticleId IdType="pubmed">32398064</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns R, Hotopf M. A systematic review describing the prognosis of chronic fatigue syndrome. Occup Med (Lond) 2005 Jan;55(1):20&#x2013;31. doi: 10.1093/occmed/kqi013. 
 
55/1/20</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqi013</ArticleId><ArticleId IdType="pubmed">15699087</ArticleId></ArticleIdList></Reference><Reference><Citation>Strayer DR, Young D, Mitchell WM. Effect of disease duration in a randomized phase III trial of rintatolimod, an immune modulator for myalgic encephalomyelitis/chronic fatigue syndrome. PLoS One. 2020 Oct 29;15(10):e0240403. doi: 10.1371/journal.pone.0240403. 
 
PONE-D-19-23982</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240403</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0240403</ArticleId><ArticleId IdType="pmc">PMC7595369</ArticleId><ArticleId IdType="pubmed">33119613</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge &#xd8;, Rekeland IG, Lien K, Th&#xfc;rmer H, Borchgrevink PC, Sch&#xe4;fer C, S&#xf8;rland K, A&#xdf;mus J, Ktoridou-Valen I, Herder I, Gotaas ME, Kvammen &#xd8;, Baranowska KA, Bohnen LM, Martinsen SS, Lonar AE, Solvang AH, Gya AE, Bruland O, Risa K, Alme K, Dahl O, Mella O. B-lymphocyte depletion in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Ann Intern Med. 2019 Apr 02;170(9):585. doi: 10.7326/m18-1451. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/m18-1451</ArticleId><ArticleId IdType="pubmed">30934066</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattie EG, Antoni MH, Fletcher MA, Czaja S, Perdomo D, Sala A, Nair S, Fu SH, Penedo FJ, Klimas N. Beyond myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) symptom severity: stress management skills are related to lower illness burden. Fatigue. 2013 Oct 11;1(4):210&#x2013;222. doi: 10.1080/21641846.2013.843255. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2013.843255</ArticleId><ArticleId IdType="pmc">PMC3837381</ArticleId><ArticleId IdType="pubmed">24278791</ArticleId></ArticleIdList></Reference><Reference><Citation>Smolensky L, Amondikar N, Crawford K, Neu S, Kopil C, Daeschler M. Fox Insight collects online, longitudinal patient-reported outcomes and genetic data on Parkinson's disease. Sci Data. 2020 Feb 24;7(1):67. doi: 10.1101/19002659. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/19002659</ArticleId><ArticleId IdType="pmc">PMC7039948</ArticleId><ArticleId IdType="pubmed">32094335</ArticleId></ArticleIdList></Reference><Reference><Citation>Long MD, Kappelman MD, Martin CF, Lewis JD, Mayer L, Kinneer PM, Sandler RS. Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results. Inflamm Bowel Dis. 2012 Nov;18(11):2099&#x2013;2106. doi: 10.1002/ibd.22895. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ibd.22895</ArticleId><ArticleId IdType="pubmed">22287300</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierson SK, Khor JS, Ziglar J, Liu A, Floess K, NaPier E, Gorzewski AM, Tamakloe M, Powers V, Akhter F, Haljasmaa E, Jayanthan R, Rubenstein A, Repasky M, Elenitoba-Johnson K, Ruth J, Jacobs B, Streetly M, Angenendt L, Patier JL, Ferrero S, Zinzani PL, Terriou L, Casper C, Jaffe E, Hoffmann C, Oksenhendler E, Foss&#xe5; A, Srkalovic G, Chadburn A, Uldrick TS, Lim M, van Rhee F, Fajgenbaum DC. ACCELERATE: a patient-powered natural history study design enabling clinical and therapeutic discoveries in a rare disorder. Cell Rep Med. 2020 Dec 22;1(9):100158. doi: 10.1016/j.xcrm.2020.100158. 
 
S2666-3791(20)30205-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2020.100158</ArticleId><ArticleId IdType="pmc">PMC7762771</ArticleId><ArticleId IdType="pubmed">33377129</ArticleId></ArticleIdList></Reference><Reference><Citation>A Registry for the ME/CFS + Long Covid Communities.  [2022-07-14].  
 https://youandmeregistry.com/
</Citation></Reference><Reference><Citation>Zhou Z, Kang H, Li S, Zhao X. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. J Neurol. 2020 Aug 26;267(8):2179&#x2013;2184. doi: 10.1007/s00415-020-09929-7. 
 
10.1007/s00415-020-09929-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09929-7</ArticleId><ArticleId IdType="pmc">PMC7249973</ArticleId><ArticleId IdType="pubmed">32458193</ArticleId></ArticleIdList></Reference><Reference><Citation>Rom&#xe1;n GC, Spencer PS, Reis J, Buguet A, Faris MEA, Katrak SM, L&#xe1;inez M, Medina MT, Meshram C, Mizusawa H, &#xd6;zt&#xfc;rk S, Wasay M, WFN Environmental Neurology Specialty Group  The neurology of COVID-19 revisited: a proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries. J Neurol Sci. 2020 Jul 15;414:116884. doi: 10.1016/j.jns.2020.116884. 
 
S0022-510X(20)30220-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.116884</ArticleId><ArticleId IdType="pmc">PMC7204734</ArticleId><ArticleId IdType="pubmed">32464367</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011 Mar 24;11(1):37. doi: 10.1186/1471-2377-11-37. 
 
1471-2377-11-37</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins F. NIH Launches New Initiative to Study &#x201c;Long COVID&#x201d;.  [2022-07-14].  
 https://www.nih.gov/about-nih/who-we-are/nih-director/statements/nih-launches-new-initiative-study-long-covid
.</Citation></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, Taylor S, Rayner C, Husain L, Greenhalgh T. Persistent symptoms after Covid-19: qualitative study of 114 "long Covid" patients and draft quality principles for services. BMC Health Serv Res. 2020 Dec 20;20(1):1144. doi: 10.1186/s12913-020-06001-y. 
 
10.1186/s12913-020-06001-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC, Houben-Wilke S, Burtin C, Posthuma R, Franssen FME, van Loon N, Hajian B, Spies Y, Vijlbrief H, van 't Hul AJ, Janssen DJA, Spruit MA. Persistent symptoms 3&#x2005;months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020 Oct;6(4):00542-2020. doi: 10.1183/23120541.00542-2020. 
 
00542-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, Redfield S, Austin JP, Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021 Aug;38:101019. doi: 10.1016/j.eclinm.2021.101019. 
 
S2589-5370(21)00299-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Trueland J. Long COVID &#x2013; We&#x2019;ve Been Here Before.  [2022-07-14].  
 https://www.bma.org.uk/news-and-opinion/long-covid-we-ve-been-here-before
.</Citation></Reference><Reference><Citation>Topol E, Verghese A, Fauci A. &#x201c;We&#x2019;re All in It Together and We&#x2019;re Gonna Get Through It&#x201d;.  [2022-07-14].  
 https://www.medscape.com/viewarticle/933619#vp_2
.</Citation></Reference><Reference><Citation>Holeman I, Kane D. Human-centered design for global health equity. Inf Technol Dev. 2019 Sep 29;26(3):477&#x2013;505. doi: 10.1080/02681102.2019.1667289. 
 
1667289</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02681102.2019.1667289</ArticleId><ArticleId IdType="pmc">PMC7484921</ArticleId><ArticleId IdType="pubmed">32982007</ArticleId></ArticleIdList></Reference><Reference><Citation>Flood M, Ennis M, Ludlow A, Sweeney FF, Holton A, Morgan S, Clarke C, Carroll P, Mellon L, Boland F, Mohamed S, De Br&#xfa;n A, Hanratty M, Moriarty F. Research methods from human-centered design: potential applications in pharmacy and health services research. Res Social Adm Pharm. 2021 Dec;17(12):2036&#x2013;2043. doi: 10.1016/j.sapharm.2021.06.015. 
 
S1551-7411(21)00231-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sapharm.2021.06.015</ArticleId><ArticleId IdType="pubmed">34229952</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacomin J. What is human centred design? Design J. 2015 Apr 28;17(4):606&#x2013;623. doi: 10.2752/175630614X14056185480186.</Citation><ArticleIdList><ArticleId IdType="doi">10.2752/175630614X14056185480186</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;ttgens I, Oertelt-Prigione S. The application of human-centered design approaches in health research and innovation: a narrative review of current practices. JMIR Mhealth Uhealth. 2021 Dec 06;9(12):e28102. doi: 10.2196/28102. 
 
v9i12e28102</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/28102</ArticleId><ArticleId IdType="pmc">PMC8691403</ArticleId><ArticleId IdType="pubmed">34874893</ArticleId></ArticleIdList></Reference><Reference><Citation>MongoDB.  [2022-07-14].  
 https://www.mongodb.com/
</Citation></Reference><Reference><Citation>Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Data Standards.  [2022-07-14].  
 https://www.commondataelements.ninds.nih.gov/Myalgic%20Encephalomyelitis/Chronic%20Fatigue%20Syndrome
.</Citation></Reference><Reference><Citation>Lupton D. Social Media, Activism, Trucker Caps: The Fascinating Story behind Long COVID.  [2022-07-14].  
 https://theconversation.com/social-media-activism-trucker-caps-the-fascinating-story-behind-long-covid-168465
.</Citation></Reference><Reference><Citation>What Is ME/CFS?  [2022-07-14].  
 https://mecfscliniciancoalition.org/about-mecfs/
</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC)  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: What is ME/CFS?  [2022-07-14].  
 https://www.cdc.gov/me-cfs/about/index.html
.</Citation></Reference><Reference><Citation>Lacerda EM, Bowman EW, Cliff JM, Kingdon CC, King EC, Lee J, Clark TG, Dockrell HM, Riley EM, Curran H, Nacul L. The UK ME/CFS Biobank for biomedical research on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and multiple sclerosis. Open J Bioresour. 2017;4:4. doi: 10.5334/ojb.28. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/ojb.28</ArticleId><ArticleId IdType="pmc">PMC5482226</ArticleId><ArticleId IdType="pubmed">28649428</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994 Dec 15;121(12):953&#x2013;959. doi: 10.7326/0003-4819-121-12-199412150-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType="pubmed">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, Lerner AM, Bested AC, Flor-Henry P, Joshi P, Powles ACP, Sherkey JA, van de Sande MI. Myalgic encephalomyelitis/chronic fatigue syndrome. J Chronic Fatigue Syndr. 2011 Dec 04;11(1):7&#x2013;115. doi: 10.1300/j092v11n01_02. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J092v11n01_02</ArticleId><ArticleId IdType="doi">10.1300/j092v11n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, Staines D, Powles ACP, Speight N, Vallings R, Bateman L, Baumgarten-Austrheim B, Bell DS, Carlo-Stella N, Chia J, Darragh A, Jo D, Lewis D, Light AR, Marshall-Gradisnik S, Mena I, Mikovits JA, Miwa K, Murovska M, Pall ML, Stevens S. Myalgic encephalomyelitis: international consensus criteria. J Intern Med. 2011 Oct;270(4):327&#x2013;338. doi: 10.1111/j.1365-2796.2011.02428.x. doi: 10.1111/j.1365-2796.2011.02428.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine of the National Academies . Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington, DC: National Academies Press; 2015.</Citation><ArticleIdList><ArticleId IdType="pubmed">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharpe MC, Archard LC, Banatvala JE, Borysiewicz LK, Clare AW, David A, Edwards RH, Hawton KE, Lambert HP, Lane RJ. A report--chronic fatigue syndrome: guidelines for research. J R Soc Med. 1991 Feb;84(2):118&#x2013;121. 
 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1293107</ArticleId><ArticleId IdType="pubmed">1999813</ArticleId></ArticleIdList></Reference><Reference><Citation>Mudie K, Est&#xe9;vez-L&#xf3;pez F, Sekulic S, Ivanovs A, Sepulveda N, Zalewski P. Recommendations for epidemiological research in ME/CFS from the EUROMENE Epidemiology Working Group. Preprints.  doi: 10.20944/preprints202009.0744.v1. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.20944/preprints202009.0744.v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware J, Sherbourne C. User's Manual for the SF-35v2 Health Survey Second Edition. Lincoln, RI: QualityMetric; 2007.</Citation></Reference><Reference><Citation>Ferrucci L, Koh C, Bandinelli S, Guralnik J. Encyclopedia of Gerontology. Amsterdam, the Netherlands: Elsevier B.V; 2007. Disability, functional status, and activities of daily living; pp. 427&#x2013;436.</Citation></Reference><Reference><Citation>Shahid A, Wilkinson K, Marcu S, Shapiro C. STOP, THAT and One Hundred Other Sleep Scales. Berlin: Springer Science+Business Media; 2012.</Citation></Reference><Reference><Citation>Smets E, Garssen B, Bonke B, De Haes J. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995 Apr;39(3):315&#x2013;325. doi: 10.1016/0022-3999(94)00125-o.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3999(94)00125-o</ArticleId><ArticleId IdType="pubmed">7636775</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacerda EM, Mudie K, Kingdon CC, Butterworth JD, O'Boyle S, Nacul L. The UK ME/CFS Biobank: a disease-specific biobank for advancing clinical research into myalgic encephalomyelitis/chronic fatigue syndrome. Front Neurol. 2018 Dec;9(12):1026. doi: 10.3389/fneur.2018.01026. doi: 10.3389/fneur.2018.01026.PMEDICINE-D-15-03679</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.01026</ArticleId><ArticleId IdType="doi">10.3389/fneur.2018.01026</ArticleId><ArticleId IdType="pmc">PMC6288193</ArticleId><ArticleId IdType="pubmed">30564186</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon DH, Shadick NA, Weinblatt ME, Frits M, Iannaccone C, Zak A, Korzenik JR. Clinical patient registry recruitment and retention: a survey of patients in two chronic disease registries. BMC Med Res Methodol. 2017 Apr 17;17(1):59. doi: 10.1186/s12874-017-0343-3. 
 
10.1186/s12874-017-0343-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-017-0343-3</ArticleId><ArticleId IdType="doi">10.1186/s12874-017-0343-3</ArticleId><ArticleId IdType="pmc">PMC5392954</ArticleId><ArticleId IdType="pubmed">28415991</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagotto E. Engaging Patients for Research that Matters: IBD Partners.  [2022-07-14].  
 https://ash.harvard.edu/publications/engaging-patients-research-matters-ibd-partners
.</Citation></Reference><Reference><Citation>Fleisher L, Bass SB, Shwarz M, Washington A, Nicholson A, Alhajji M, Geynisman DM, Maurer L, Greener J, Kenny C. Using theory and user-centered design in digital health: the development of the mychoice communication tool to prepare patients and improve informed decision making regarding clinical trial participation. Psychooncology. 2020 Jan 02;29(1):114&#x2013;122. doi: 10.1002/pon.5254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pon.5254</ArticleId><ArticleId IdType="pubmed">31654442</ArticleId></ArticleIdList></Reference><Reference><Citation>Azeez-Narain K. Can Human-Centered Design Help Create Better Digital Health Solutions?  [2022-07-14].  
 https://www.healthtechmagazines.com/can-human-centered-design-help-create-better-digital-health-solutions/
</Citation></Reference><Reference><Citation>All of Us Research Program Investigators  The &#x201c;All of Us&#x201d; research program. N Engl J Med. 2019 Aug 15;381(7):668&#x2013;676. doi: 10.1056/nejmsr1809937. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsr1809937</ArticleId><ArticleId IdType="doi">10.1056/nejmsr1809937</ArticleId><ArticleId IdType="pmc">PMC8291101</ArticleId><ArticleId IdType="pubmed">31412182</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson EC, Dixon-Woods M, Batalden PB, Homa K, Van Citters AD, Morgan TS, Eftimovska E, Fisher ES, Ovretveit J, Harrison W, Lind C, Lindblad S. Patient focused registries can improve health, care, and science. BMJ. 2016 Jul 01;354:i3319. doi: 10.1136/bmj.i3319. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i3319</ArticleId><ArticleId IdType="pmc">PMC5367618</ArticleId><ArticleId IdType="pubmed">27370543</ArticleId></ArticleIdList></Reference><Reference><Citation>Inwald EC, Koller M, Klinkhammer-Schalke M, Zeman F, Hofst&#xe4;dter F, Gerstenhauer M, Brockhoff G, Ortmann O. 4-IHC classification of breast cancer subtypes in a large cohort of a clinical cancer registry: use in clinical routine for therapeutic decisions and its effect on survival. Breast Cancer Res Treat. 2015 Oct 14;153(3):647&#x2013;658. doi: 10.1007/s10549-015-3572-3. 
 
10.1007/s10549-015-3572-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10549-015-3572-3</ArticleId><ArticleId IdType="pmc">PMC4589562</ArticleId><ArticleId IdType="pubmed">26369534</ArticleId></ArticleIdList></Reference><Reference><Citation>Fereshtehnejad S, Damangir S, Cermakova P, Aarsland D, Eriksdotter M, Religa D. Comorbidity profile in dementia with Lewy bodies versus Alzheimer's disease: a linkage study between the Swedish Dementia Registry and the Swedish National Patient Registry. Alzheimers Res Ther. 2014 Oct 6;6(5-8):65. doi: 10.1186/s13195-014-0065-2. 
 
s13195-014-0065-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-014-0065-2</ArticleId><ArticleId IdType="doi">10.1186/s13195-014-0065-2</ArticleId><ArticleId IdType="pmc">PMC4255539</ArticleId><ArticleId IdType="pubmed">25478027</ArticleId></ArticleIdList></Reference><Reference><Citation>Althubaiti A. Information bias in health research: definition, pitfalls, and adjustment methods. J Multidiscip Healthc. 2016 May;:211. doi: 10.2147/jmdh.s104807.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/jmdh.s104807</ArticleId><ArticleId IdType="pmc">PMC4862344</ArticleId><ArticleId IdType="pubmed">27217764</ArticleId></ArticleIdList></Reference><Reference><Citation>Yancey AK, Ortega AN, Kumanyika SK. Effective recruitment and retention of minority research participants. Annu Rev Public Health. 2006 Apr 01;27(1):1&#x2013;28. doi: 10.1146/annurev.publhealth.27.021405.102113. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.publhealth.27.021405.102113</ArticleId><ArticleId IdType="pubmed">16533107</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang M, Vorderstrasse A. Socioeconomic status and racial or ethnic differences in participation: web-based survey. JMIR Res Protoc. 2019 Apr 10;8(4):e11865. doi: 10.2196/11865. 
 
v8i4e11865</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/11865</ArticleId><ArticleId IdType="pmc">PMC6479282</ArticleId><ArticleId IdType="pubmed">30969173</ArticleId></ArticleIdList></Reference><Reference><Citation>Grady C, Wiener L, Abdoler E, Trauernicht E, Zadeh S, Diekema DS, Wilfond BS, Wendler D. Assent in research: the voices of adolescents. J Adolesc Health. 2014 May;54(5):515&#x2013;520. doi: 10.1016/j.jadohealth.2014.02.005. 
 
S1054-139X(14)00073-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jadohealth.2014.02.005</ArticleId><ArticleId IdType="pmc">PMC4047975</ArticleId><ArticleId IdType="pubmed">24630932</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown DL, Cowdery JE, Jones TS, Langford A, Gammage C, Jacobs TL. Adolescent knowledge and attitudes related to clinical trials. Clin Trials. 2015 Jun 10;12(3):212&#x2013;214. doi: 10.1177/1740774515571443. 
 
1740774515571443</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1740774515571443</ArticleId><ArticleId IdType="pubmed">25673637</ArticleId></ArticleIdList></Reference><Reference><Citation>American College of Obstetricians and Gynecologists  Guidelines for Adolescent Health Research - Committee Opinion No 665.  [2022-07-14].  
 https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2016/06/guidelines-for-adolescent-health-research
.</Citation></Reference><Reference><Citation>Jason LA, Benton MC, Valentine L, Johnson A, Torres-Harding S. The economic impact of ME/CFS: individual and societal costs. Dyn Med. 2008 Apr 08;7(1):6. doi: 10.1186/1476-5918-7-6. 
 
1476-5918-7-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-5918-7-6</ArticleId><ArticleId IdType="doi">10.1186/1476-5918-7-6</ArticleId><ArticleId IdType="pmc">PMC2324078</ArticleId><ArticleId IdType="pubmed">18397528</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Katz BZ, Sunnquist M, Torres C, Cotler J, Bhatia S. The prevalence of pediatric myalgic encephalomyelitis/chronic fatigue syndrome in a community&#x2011;based sample. Child Youth Care Forum. 2020 Aug 23;49(4):563&#x2013;579. doi: 10.1007/s10566-019-09543-3. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10566-019-09543-3</ArticleId><ArticleId IdType="pmc">PMC8186295</ArticleId><ArticleId IdType="pubmed">34113066</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>